Enhancing the Quality and Efficiency of Analytical Method Development as Part of the Quality by Design Framework

Highlights of Analytical Chemistry in Switzerland

Authors

  • Christoph Meyer Novartis Pharma AG, PHAD Oral Dosage Forms 2, Forum 1, Novartis Campus, CH-4056 Basel;, Email: christoph.meyer@novartis.com
  • Tomislav Soldo
  • undine Kettenring

DOI:

https://doi.org/10.2533/chimia.2010.825

Keywords:

Analytical method development and validation, Design of experiments(doe), Drug substance (ds) and drug product (dp), Failure mode effects analysis (fmea), Fishbone, Hplc, International committee on harmonization (ich) guidelines, Quality by design (qbd)
CHIMIA Vol. 64 No. 11 (2010): Swiss Biotech

Downloads

Published

2010-11-26

Issue

Vol. 64 No. 11 (2010): Swiss Biotech

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2010 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

[1]
C. Meyer, T. Soldo, undine Kettenring, Chimia 2010, 64, 825, DOI: 10.2533/chimia.2010.825.